共 50 条
- [42] Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (03): : 827 - 836
- [43] Predicting the Risk of Recurrence Before the Start of Antithyroid Drug Therapy in Patients With Graves' Hyperthyroidism JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (04): : 1381 - 1389
- [45] Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves' Disease JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (10): : e1881 - e1888
- [46] Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease? Nutrition & Metabolism, 7
- [48] TESTOSTERONE AND ITS BINDING IN HYPERTHYROID WOMEN BEFORE AND UNDER ANTITHYROID DRUG-THERAPY ACTA ENDOCRINOLOGICA, 1989, 121 (03): : 443 - 446
- [50] Graves' hyperthyroidism: how long should antithyroid drug therapy be continued to achieve remission? NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2006, 2 (01): : 2 - 3